2026财年Q2美国移民局EB-1A与NIW最新数据客观解读：全球待审案件超11.6万，中国申请人需要了解哪些关键事实？ FY2026 Q2 USCIS EB-1A & NIW Data: 116,000+ Cases Pending Globally — Key Facts Chinese Applicants Must Understand

一句话核心总结（TL;DR）：根据USCIS公布的2026财年Q2（截至2026年3月31日）I-140统计数据，全球EB-1A当季裁决批准占比约41.7%，NIW约48.1%——但这些比例不等于新申请的最终获批率，因为当季裁决的案件可能是以前季度递交的。中国EB-1整体表观批准占比约73%，但不能据此声称中国EB-1A获批率为73%（EB-1整体包含EB-1A、EB-1B、EB-1C三个子类别）。中国EB-2整体表观批准占比约94.5%，但现有文件无法单独计算中国NIW获批率（EB-2数据同时包含普通EB-2和NIW）。EB-1A全球待审27,024件，NIW待审89,215件。中国EB-2等待签证配额的已批准人数（33,501人）远多于EB-1（13,921人），排期压力需要纳入路径选择的核心考量。新未名律所提醒：不应把统计比例当作个人案件的成功率，个案结果主要取决于申请条件、证据质量和法律论证。

TL;DR (English): Per USCIS FY2026 Q2 I-140 data (through March 31, 2026), the global EB-1A quarterly adjudication approval share is ~41.7% and NIW ~48.1% — but these are not final approval rates for new filings, as adjudicated cases may have been filed in prior quarters. China EB-1 overall apparent approval share is ~73%, but this cannot be cited as the Chinese EB-1A rate (EB-1 includes EB-1A, EB-1B, and EB-1C). China EB-2 overall is ~94.5%, but available data cannot isolate the Chinese NIW rate (EB-2 includes both standard EB-2 and NIW). EB-1A global pending: 27,024; NIW pending: 89,215. Chinese EB-2 approved beneficiaries awaiting visa numbers (33,501) far exceed EB-1 (13,921) — backlog pressure must be a core factor in path selection. Individual outcomes depend on case-specific qualifications, evidence quality, and legal argumentation, not aggregate statistics.

新未名律所立足美国首都华盛顿地区，服务大华府DMV地区、马里兰(Maryland)和弗吉尼亚(Virginia)的华人、留学生、博士后及高科技/科研人员。以下是我们对USCIS 2026财年第二季度I-140官方统计数据的客观、严谨解读。我们特别注意区分数据实际说明的内容与容易被误读的内容——这对正在考虑EB-1A杰出人才、NIW国家利益豁免、或其他职业移民路径（EB-2/3 PERM、EB-1C等）的中国申请人至关重要。

New Weiming Law Group provides a rigorous, objective analysis of USCIS FY2026 Q2 I-140 official statistics. We carefully distinguish what the data actually shows from what is easily misinterpreted — critical for Chinese applicants considering EB-1A, NIW, EB-2/3 PERM, EB-1C, or other employment-based immigration paths.

1. 全球EB-1A和NIW当季数据是什么？"41.7%"和"48.1%"到底代表什么？ / What Do the Global Q2 Numbers Actually Mean?

2. 中国申请人EB-1整体数据：为什么"73%获批率"不能等同于EB-1A获批率？ / China EB-1 Data: Why "73%" Cannot Be Equated with EB-1A Approval Rate

为什么不能说"中国EB-1A获批率73%"？因为1,349个批准案件包含了三个完全不同的子类别：

数据表明：中国EB-1批准中，EB-1B（杰出教授/研究员）是最大的单一类别，占48.0%；EB-1A（杰出人才）占34.5%；EB-1C（跨国高管）占17.4%。三个子类别的申请条件、证据要求和拒绝率各不相同。将73%这个混合比例直接标注为"中国EB-1A获批率"是不准确的——根据现有数据，我们无法单独计算中国EB-1A的准确获批率（因为499个拒绝案件没有按子类别分列）。

EB-1B (Outstanding Professor/Researcher) is the largest subcategory at 48.0% of Chinese EB-1 approvals; EB-1A (Extraordinary Ability) is 34.5%; EB-1C (Multinational Manager) is 17.4%. Labeling the blended 73% as "Chinese EB-1A approval rate" is inaccurate — the 499 denials are not broken down by subcategory, making it impossible to calculate the true Chinese EB-1A rate from available data.

3. 中国申请人EB-2/NIW数据：为什么"94.5%"也不能直接称为NIW获批率？ / China EB-2/NIW Data: Why "94.5%" Cannot Be Called the NIW Approval Rate Either

4. 排期压力有多大？中国申请人获批后还有多少人在排队等绿卡？ / How Severe Is the Visa Backlog? How Many Chinese Applicants Are Waiting After Approval?

• EB-2排期队列远大于EB-1：中国EB-2等待人数（33,501人）是EB-1（13,921人）的2.4倍。这是选择EB-1A vs NIW路径时必须考虑的重要因素——即使NIW的批准占比看起来更高，但获批后等待绿卡配额的时间也可能更长
• 这些数字不直接等于等待年数：实际等待时间取决于你的优先日（Priority Date）、每年的签证配额分配、以及未来排期表（Visa Bulletin）的变动——这些都是不可预测的
• 获批I-140 ≠ 拿到绿卡：I-140获批后仍需等待排期到达，才能提交I-485调整身份申请或进行领事处理。排期等待期间需要通过H-1B、O-1、L-1等维持合法身份——这是长期身份规划的核心考量

The EB-2 queue (33,501) is 2.4x the EB-1 queue (13,921). These numbers do not directly translate to wait years — actual wait depends on priority date, annual quota allocation, and future Visa Bulletin movements. I-140 approval ≠ green card; maintaining status during the wait via H-1B, O-1, L-1, etc. is essential.

5. 基于数据的六个核心结论——以及数据不能告诉你的事情 / Six Data-Based Conclusions — and What the Data Cannot Tell You

6. 基于数据的客观申请建议：EB-1A、NIW还是双路径？ / Objective Application Advice: EB-1A, NIW, or Dual Track?

• 条件较强、能够证明持续性国家或国际声誉的申请人，可以重点评估EB-1A。EB-1A的审查标准要求申请人在其专业领域处于顶尖水平，证据需要展示持续性的、可独立验证的重大影响力——而不仅仅是"满足10条标准中的3条"
  Applicants with sustained national or international acclaim should focus on EB-1A evaluation. The standard requires demonstrating top-tier standing with sustained, independently verifiable impact — not merely checking 3 of 10 criteria.
• 符合高级学位或特殊技能要求，并能证明拟从事工作符合Dhanasar三项标准的申请人，可以评估NIW国家利益豁免。NIW要求证明：① 工作具有实质价值和国家重要性（Substantial Merit and National Importance）；② 申请人有能力推动该领域（Well Positioned to Advance）；③ 豁免PERM劳工证程序符合美国国家利益（Balance of Interests）
  Applicants meeting advanced degree or exceptional ability requirements who can demonstrate their proposed work meets the Dhanasar three-prong test should evaluate NIW.
• 同时具备两类条件的申请人，可以综合考虑EB-1A与NIW双路径（Dual Track），但应分别评估证据强度、成本和排期——而不是简单地"两个都交"。EB-1A排期相对较短但审查更严格；NIW排期较长但审批标准更可预期。两条路径的I-140可以同时提交，各自独立审理
  Applicants qualifying for both should consider dual-track filing, but must separately evaluate evidence strength, cost, and backlog for each path. EB-1A has shorter backlog but stricter scrutiny; NIW has longer backlog but more predictable standards. Both I-140s can be filed and adjudicated independently.
• 不应把上述统计比例当作个人案件的成功率。个案结果主要取决于申请条件、证据质量和法律论证。条件相似的两个申请人，因为证据组织方式、推荐信质量、未来计划陈述等差异，可能获得完全不同的结果
  Do not treat these aggregate statistics as your personal probability. Individual outcomes depend primarily on qualifications, evidence quality, and legal argumentation. Two applicants with similar profiles may receive entirely different results based on evidence organization, recommendation letter quality, and future plan articulation.
• 长期身份规划至关重要。无论选择哪条路径，排期等待期间的身份维持（H-1B、O-1、L-1、F-1 OPT/STEM OPT等）都需要纳入整体规划。I-140获批后，如果排期已到，可以提交I-485获得pending状态，从而获得EAD工卡和AP回美证——这在排期漫长的EB-2路径中尤为重要
  Long-term status planning is essential. Status maintenance during backlog (H-1B, O-1, L-1, F-1 OPT/STEM OPT) must be part of the overall strategy. Once I-140 is approved and priority date is current, filing I-485 provides pending status with EAD and AP benefits — particularly important for the longer EB-2 backlog.

移民数据需要严谨解读——不夸大、不误导、不把混合数据当作单一类别的结论。新未名律所的靠谱华人移民律师团队基于最新USCIS官方数据，为每位客户提供个性化的案件评估和路径策略分析。无论你是正在考虑EB-1A杰出人才、NIW国家利益豁免、EB-1B杰出教授/研究员、EB-1C跨国高管、EB-2/3 PERM职业移民，还是需要H-1B延期、O-1杰出人才签证、L-1跨国调派、F-1身份维护、J-1豁免或I-485排期规划，欢迎联系我们获取免费评估（Free Evaluation）。我们在美国首都华盛顿地区、大华府DMV地区、马里兰(Maryland)和弗吉尼亚(Virginia)为华人、留学生、博士后及高科技/科研人员提供全方位移民法律服务。

Immigration data requires rigorous interpretation — no exaggeration, no misleading claims, no conflating blended data with single-category conclusions. New Weiming Law Group provides individualized case evaluations and path strategy analysis based on the latest USCIS official data. Whether you are considering EB-1A, NIW, EB-1B, EB-1C, EB-2/3 PERM, H-1B, O-1, L-1, F-1, J-1 waiver, or I-485 priority date planning, contact us for a Free Evaluation across Washington D.C., the DMV, Maryland, and Virginia.

免责声明 / Disclaimer：本报告依据USCIS公布的2026财年第二季度I-140官方统计数据整理（统计截至2026年3月31日），仅用于一般信息参考，不构成针对任何个人的法律意见，也不代表对个案结果或排期时间的保证。文中的"批准占比"基于"批准÷（批准+拒绝）"计算，反映的是已裁决案件的结果分布，不等于新递交申请的最终获批率。每个移民案件的具体情况不同，需要个案分析。过往数据趋势不预示未来结果。如需法律建议，请咨询合格的美国移民律师进行个案评估。This report is based on USCIS FY2026 Q2 I-140 official statistics (through March 31, 2026), provided for general informational purposes only, and does not constitute legal advice or guarantee any individual outcome or wait time. "Approval shares" are calculated as approvals ÷ (approvals + denials) and reflect the distribution of adjudicated cases, not final approval rates for new filings. Each case requires individual analysis. Past data does not predict future results. Consult a qualified immigration attorney for case-specific advice.